Cargando…
A Basis for Rapid Clearance of Circulating Ring-Stage Malaria Parasites by the Spiroindolone KAE609
Recent clinical trials revealed a surprisingly rapid clearance of red blood cells (RBCs) infected with malaria parasites by the spiroindolone KAE609. Here, we show that ring-stage parasite–infected RBCs exposed to KAE609 become spherical and rigid, probably through osmotic dysregulation consequent t...
Autores principales: | Zhang, Rou, Suwanarusk, Rossarin, Malleret, Benoit, Cooke, Brian M., Nosten, Francois, Lau, Yee-Ling, Dao, Ming, Lim, Chwee Teck, Renia, Laurent, Tan, Kevin Shyong Wei, Russell, Bruce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676544/ https://www.ncbi.nlm.nih.gov/pubmed/26136472 http://dx.doi.org/10.1093/infdis/jiv358 |
Ejemplares similares
-
Pharmacokinetic-Pharmacodynamic Analysis of Spiroindolone Analogs and KAE609 in a Murine Malaria Model
por: Lakshminarayana, Suresh B., et al.
Publicado: (2015) -
Comparative chemical genomics reveal that the spiroindolone antimalarial KAE609
(Cipargamin) is a P-type ATPase inhibitor
por: Goldgof, Gregory M., et al.
Publicado: (2016) -
Therapeutic disruption of Plasmodium vivax infected red cell deformability
por: Zhang, Rou, et al.
Publicado: (2014) -
A first-in-human randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study of novel spiroindolone KAE609, to assess the safety, tolerability and pharmacokinetics in healthy adult volunteers
por: Leong, Joel, et al.
Publicado: (2014) -
Efficacy of Cipargamin (KAE609) in a Randomized, Phase II Dose-Escalation Study in Adults in Sub-Saharan Africa With Uncomplicated Plasmodium falciparum Malaria
por: Schmitt, Esther K, et al.
Publicado: (2021)